drugset / Trial / NCT05365477

Empiric Versus Selective Prevention Strategies for Kidney Stone Disease

NCT05365477

Phase 4 Completed 56 enrolled Vanderbilt University Medical Center
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The aims of this study are to 1) Conduct a randomized clinical trial of selective versus empiric diet plus pharmacologic therapy in high-risk stone formers and 2) Determine adverse effects from, and adherence to selective and empiric strategies.

Timeline

Start
2022-08-04
Primary completion
2025-09-26
Completion
2026-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Allopurinol Small molecule 300 mg
Comparator Indapamide Small molecule 1.25 mg
Comparator Indapamide Small molecule 2.5 mg
Comparator POTASSIUM CITRATE ANHYDROUS Small molecule 15 meq
Comparator POTASSIUM CITRATE ANHYDROUS Small molecule 30 meq
Subject Potassium Chloride Small molecule 20 meq

Indications